Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BioAmber financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2019-11-21
Market Capitalization
$8.3 M
2018-05-31
Revenue
$14.9 M
FY, 2017
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|
| Revenue | 2.2M | 8.3M | 14.9M |
| Revenue growth, % | 41.0% | 280.9% | 80.6% |
| Cost of goods sold | 2.6M | 13.7M | 22.3M |
| Gross profit | (440.8K) | (5.4M) | (7.4M) |
| Gross profit margin, % | -20.3% | -65.2% | -49.4% |
| General and administrative expense | 10.6M | 9.5M | 12.4M |
| Operating expense total | 34.9M | 24.2M | 102.6M |
| Depreciation and amortization | 1.1M | 4.8M | 5.1M |
| EBIT | (29.6M) | (110.0M) | |
| EBIT margin, % | -358.2% | -736.2% | |
| Pre tax profit | (41.2M) | (28.2M) | (102.1M) |
| Income tax expense | (3.8K) | 25.6K | 81.7K |
| Net Income | (22.5M) | (98.2M) |